Become a part of real change in groundbreaking fetal-maternal medicine.
An FDA Breakthrough device
DelivAssure has already received FDA Breakthrough device designation and is protected by wide reaching patents.
A burgeoning need
Obstetrics is one of the final frontiers of medicine without a basic diagnostic tool for measuring distress and the complications are growing.
A world-class team
VitalTrace can continue in-house R&D and bring DelivAssure to market with a global network of leading obstetricians and entrepreneurs.
An evergreen market
Childbirth is experienced by everyone and obstetricians have indicated that the device could be used in 50% of all births world-wide.
Why Invest?
Novel technology
VitalTrace is well positioned to capitalize on decades of development from glucose sensors and bring obstetrics into the modern era.
Seamless integration
Insertion is identical to a fetal scalp electrode, already used in 22% of births, to increase adoption and ease of use.